Position in AMGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,049,060
+$47,344 QoQ
Shares Held
2,897
+1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,674
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 58%
Shared 42%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NICHOLS & PRATT ADVISERS LLP /MA holds $207,768,859 across 8 Drug Manufacturers - General names. AMGN ranks #6 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
460,889 | $117,051,979 | |
| 2 | MRK |
Merck & Co., Inc.
|
442,799 | $56,899,671 | |
| 3 | NVO |
Novo Nordisk A S
|
477,675 | $22,899,738 | |
| 4 | ABBV |
AbbVie Inc.
|
24,617 | $6,194,621 | |
| 5 | NVS |
Novartis AG
|
17,297 | $2,710,784 | |
| 6 | AMGN |
Amgen Inc
This page
|
2,897 | $1,049,060 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,525 | $548,830 | |
| 8 | PFE |
Pfizer Inc
|
17,200 | $414,176 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,049,060 | 2,897 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,001,716 | 2,847 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $931,851 | 2,847 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $859,863 | 3,047 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $850,752 | 3,047 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $960,820 | 3,084 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $862,457 | 3,309 | Shares | Other | 2025-02-05 | |
| 2024-09-30 | $1,335,237 | 4,144 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,326,037 | 4,244 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,249,301 | 4,394 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $1,467,173 | 5,094 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,369,063 | 5,094 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,007,304 | 4,537 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,106,006 | 4,575 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,201,578 | 4,575 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $895,965 | 3,975 | Shares | Other | 2022-11-01 | |
| 2022-06-30 | $991,447 | 4,075 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $985,416 | 4,075 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $916,752 | 4,075 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $935,660 | 4,400 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $1,072,500 | 4,400 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,119,645 | 4,500 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,034,640 | 4,500 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,143,720 | 4,500 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,061,370 | 4,500 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $912,285 | 4,500 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||